Literature DB >> 1589732

Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study.

M Lappalainen1, P Koskela, K Hedman, K Teramo, P Ammälä, V Hiilesmaa, M Koskiniemi.   

Abstract

Congenital toxoplasmosis may develop after maternal primary infection during pregnancy. Since toxoplasmosis in adults is usually asymptomatic, the only way to find the pregnancies at risk of acute toxoplasmosis (i.e. seronegative mothers) is to perform serological screening of all pregnant women. We studied toxoplasma-specific antibodies in 16,733 pregnant women in the first, second, and third trimesters over an 18-month period in the Helsinki area, with a population of 820,700. The participation rate in our study was 90.2% of all pregnancies in the area. The overall prevalence of toxoplasma seropositivity was 20.3%. The incidence of primary infection was 2.4/1000 pregnancies at risk. Our data on incidence suggest an annual occurrence of 131 cases of primary toxoplasma infections during pregnancy in Finland. Primary toxoplasma infection appears to be a significant risk to the fetus even in countries where the prevalence of toxoplasma seropositivity is low. The feasibility of mass screening for toxoplasma infections during pregnancy should be considered in order to reduce the morbidity and mortality due to congenital toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589732     DOI: 10.3109/00365549209048407

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  16 in total

1.  Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia.

Authors:  V Punda-Polić; M Tonkić; V Capkun
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Gestational and neonatal toxoplasmosis: regional seroprevalence in the United Arab Emirates.

Authors:  F K Dar; T Alkarmi; S Uduman; Y Abdulrazzaq; H Grundsell; P Hughes
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

3.  Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil.

Authors:  Rogerio S Vaz; Vanete Thomaz-Soccol; Elaine Sumikawa; Ana Teresa B Guimarães
Journal:  Parasitol Res       Date:  2010-02       Impact factor: 2.289

4.  Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

Authors:  P A Jenum; B Stray-Pedersen
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Status of toxoplasma antibodies in recurrent fetal loss in U.A.E. women.

Authors:  N Singh
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

6.  Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women.

Authors:  P A Jenum; B Stray-Pedersen; K K Melby; G Kapperud; A Whitelaw; A Eskild; J Eng
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 7.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

8.  Radiological signs in newborns exposed to primary Toxoplasma infection in utero.

Authors:  K Virkola; M Lappalainen; L Valanne; M Koskiniemi
Journal:  Pediatr Radiol       Date:  1997-02

9.  Contact with pigs and cats associated with high prevalence of Toxoplasma antibodies among farmers.

Authors:  M Seuri; P Koskela
Journal:  Br J Ind Med       Date:  1992-12

10.  Modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards.

Authors:  S P Parker; W D Cubitt
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.